EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A review of etripamil: A new paradigm for treating paroxysmal supraventricular tachycardia for an informed, shared decision

James E Ip

Heart Rhythm · 2026

DOI: 10.1016/j.hrthm.2026.01.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Heart Rhythm, 2026. Verfasst von James E Ip. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York. Electronic address: jei900…. Hauptthemen laut MEDLINE: Tachycardia, Supraventricular, Tachycardia, Paroxysmal, Decision Making, Shared. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paroxysmal supraventricular tachycardia (PSVT) is associated with significant morbidity and affects 1 in 300 people. This article reviews the contemporary management of PSVT and the potential role of intranasal etripamil, a recently Food and Drug Administration-approved intranasal calcium channel blocker that can be used to safely and effectively terminate PSVT in an outpatient setting and avoid urgent medical attention. When combined with the use of wearable devices, this paradigm shift of enabling patients to self-treat PSVT with an on-demand therapy provides another option to be considered in shared decision making for PSVT management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, SupraventricularTachycardia, ParoxysmalDecision Making, SharedHumansAdministration, IntranasalCalcium Channel BlockersAnti-Arrhythmia Agents

Stichwörter der Autor:innen

EtripamilParoxysmal supraventricular tachycardiaReviewSmartwatchTreatmentWearables

Substanzen

Calcium Channel BlockersAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Medicine, Division of Cardiology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York. Electronic address: jei9008@med.cornell.edu.

Zitieren

APA

Ip, J. E. (2026). A review of etripamil: A new paradigm for treating paroxysmal supraventricular tachycardia for an informed, shared decision. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2026.01.016

Vancouver

Ip JE. A review of etripamil: A new paradigm for treating paroxysmal supraventricular tachycardia for an informed, shared decision. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2026.01.016

BibTeX
@article{Ip2026,
  author = {Ip, James E},
  title = {A review of etripamil: A new paradigm for treating paroxysmal supraventricular tachycardia for an informed, shared decision},
  journal = {Heart Rhythm},
  year = {2026},
  doi = {10.1016/j.hrthm.2026.01.016}
}
Kostenlos starten →